bibliographicCitation |
Cheng P, Zhang X, Wang X, Liu C, Zhao X, Fan J, Xu C. Identification of evodiamine as a suppressor of prostate cancer progression by reducing AR transcriptional activity via targeting Src. Endocrine. 2022 Feb;75(2):635–45. doi: 10.1007/s12020-021-02907-7. PMID: 34713388. |